Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FERMENTA BIOTECH vs GLAND PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FERMENTA BIOTECH GLAND PHARMA FERMENTA BIOTECH/
GLAND PHARMA
 
P/E (TTM) x 122.7 42.0 292.4% View Chart
P/BV x 3.6 3.3 107.3% View Chart
Dividend Yield % 0.4 1.1 32.9%  

Financials

 FERMENTA BIOTECH   GLAND PHARMA
EQUITY SHARE DATA
    FERMENTA BIOTECH
Mar-24
GLAND PHARMA
Mar-24
FERMENTA BIOTECH/
GLAND PHARMA
5-Yr Chart
Click to enlarge
High Rs2142,196 9.7%   
Low Rs104862 12.1%   
Sales per share (Unadj.) Rs116.3343.9 33.8%  
Earnings per share (Unadj.) Rs-8.346.9 -17.7%  
Cash flow per share (Unadj.) Rs0.267.8 0.4%  
Dividends per share (Unadj.) Rs1.2520.00 6.3%  
Avg Dividend yield %0.81.3 60.1%  
Book value per share (Unadj.) Rs95.6529.6 18.1%  
Shares outstanding (eoy) m28.87164.71 17.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.44.4 30.8%   
Avg P/E ratio x-19.132.6 -58.7%  
P/CF ratio (eoy) x646.222.5 2,866.7%  
Price / Book Value ratio x1.72.9 57.6%  
Dividend payout %-15.042.6 -35.3%   
Avg Mkt Cap Rs m4,591251,781 1.8%   
No. of employees `000NANA-   
Total wages/salary Rs m58512,569 4.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,35756,647 5.9%  
Other income Rs m1181,702 6.9%   
Total revenues Rs m3,47558,350 6.0%   
Gross profit Rs m20513,331 1.5%  
Depreciation Rs m2473,446 7.2%   
Interest Rs m174262 66.5%   
Profit before tax Rs m-9911,325 -0.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1413,601 3.9%   
Profit after tax Rs m-2407,725 -3.1%  
Gross profit margin %6.123.5 25.9%  
Effective tax rate %-143.231.8 -450.3%   
Net profit margin %-7.213.6 -52.5%  
BALANCE SHEET DATA
Current assets Rs m2,62656,452 4.7%   
Current liabilities Rs m1,94113,984 13.9%   
Net working cap to sales %20.475.0 27.2%  
Current ratio x1.44.0 33.5%  
Inventory Days Days2650 50.9%  
Debtors Days Days759100 756.0%  
Net fixed assets Rs m2,93749,657 5.9%   
Share capital Rs m144165 87.7%   
"Free" reserves Rs m2,61787,060 3.0%   
Net worth Rs m2,76187,225 3.2%   
Long term debt Rs m4251,065 39.9%   
Total assets Rs m5,563106,108 5.2%  
Interest coverage x0.444.2 1.0%   
Debt to equity ratio x0.20 1,261.2%  
Sales to assets ratio x0.60.5 113.0%   
Return on assets %-1.27.5 -15.7%  
Return on equity %-8.78.9 -98.2%  
Return on capital %2.413.1 18.1%  
Exports to sales %063.1 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA35,764 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,20735,764 3.4%   
Fx outflow Rs m09,401 0.0%   
Net fx Rs m1,20726,363 4.6%   
CASH FLOW
From Operations Rs m1,0539,968 10.6%  
From Investments Rs m-155-17,569 0.9%  
From Financial Activity Rs m-909-7,994 11.4%  
Net Cashflow Rs m-10-15,518 0.1%  

Share Holding

Indian Promoters % 54.5 0.0 -  
Foreign collaborators % 7.6 51.8 14.7%  
Indian inst/Mut Fund % 0.1 39.8 0.1%  
FIIs % 0.1 4.5 1.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.9 48.2 78.8%  
Shareholders   13,221 122,358 10.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FERMENTA BIOTECH With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on DIL LIMITED vs GLAND PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

DIL LIMITED vs GLAND PHARMA Share Price Performance

Period DIL LIMITED GLAND PHARMA S&P BSE HEALTHCARE
1-Day 2.49% -1.50% 0.97%
1-Month 13.56% 6.96% -0.50%
1-Year 119.74% 2.40% 43.25%
3-Year CAGR 7.18% -20.71% 20.25%
5-Year CAGR 9.24% -0.65% 26.18%

* Compound Annual Growth Rate

Here are more details on the DIL LIMITED share price and the GLAND PHARMA share price.

Moving on to shareholding structures...

The promoters of DIL LIMITED hold a 62.1% stake in the company. In case of GLAND PHARMA the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of DIL LIMITED and the shareholding pattern of GLAND PHARMA.

Finally, a word on dividends...

In the most recent financial year, DIL LIMITED paid a dividend of Rs 1.3 per share. This amounted to a Dividend Payout ratio of -15.0%.

GLAND PHARMA paid Rs 20.0, and its dividend payout ratio stood at 42.6%.

You may visit here to review the dividend history of DIL LIMITED, and the dividend history of GLAND PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5% Sensex Today Trades Higher | Nifty Above 23,450 | Info Edge & SJVN Jump 5%(10:30 am)

Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.